Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATGross ProfitLong-Term Debt IssuancesReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Skinvisible (SKVI) Receivables - Other (2016 - 2023)

Skinvisible (SKVI) has disclosed Receivables - Other for 13 consecutive years, with $21592.0 as the latest value for Q4 2023.

  • Quarterly Receivables - Other rose 53.43% to $21592.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $21592.0 through Dec 2023, up 53.43% year-over-year, with the annual reading at $21592.0 for FY2023, 53.43% up from the prior year.
  • Receivables - Other hit $21592.0 in Q4 2023 for Skinvisible, up from $14073.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $68899.0 in Q4 2019 to a low of $399.0 in Q2 2019.
  • Historically, Receivables - Other has averaged $16136.4 across 4 years, with a median of $9306.5 in 2019.
  • Biggest YoY gain for Receivables - Other was 5917.38% in 2019; the steepest drop was 96.01% in 2019.
  • Year by year, Receivables - Other stood at $68899.0 in 2019, then plummeted by 93.66% to $4370.0 in 2020, then surged by 222.04% to $14073.0 in 2022, then skyrocketed by 53.43% to $21592.0 in 2023.
  • Business Quant data shows Receivables - Other for SKVI at $21592.0 in Q4 2023, $14073.0 in Q4 2022, and $4370.0 in Q2 2020.